tirzepatide adolescent obesity trial for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program Tirzepatide for Older Adults with

Poor sleep, stress, or emotional eating can contribute to plateaus

Caprylic Acid & Probiotics to Combat Yeast, Severe Sugar Cravings & Candida

Side Effects Head-to-Head Around 80% of participants in clinical trials reported side effects from Wegovy, while gastrointestinal side effects are the most common with Orlistat, affecting about 1 in 10 people

Eli Lilly may submit its dossier for first round evaluation after TRIUMPH-3 (pending positive outcomes), so at the earliest, late 2026 seems like a realistic estimation, if not later into early 2027 after TRIUMPH-5 has finished

Warnings f you are pregnant, breastfeeding, taking medication, or planning to undergo any medical procedure, consult your doctor before use

Available strengths range from 0.25 mg up to 2.5 mg weekly, with total peptide content adjusted accordingly (weekly dose 4)